Multiple Myeloma

• CLINICAL_TRIALS trial_result · 2016-01-27
  Clinical Trial Update: Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function [Phase 1]

  Phase 1 study evaluating elotuzumab in combination with lenalidomide and dexamethasone in multiple myeloma across different renal function l…

• CLINICAL_TRIALS trial_result · 2016-01-26
  Clinical Trial Update: Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma [Phase 2]

  A Phase 2 trial evaluated whether adding elotuzumab to bortezomib and dexamethasone improves outcomes in relapsed or refractory multiple mye…

• CLINICAL_TRIALS trial_result · 2016-01-25
  Clinical Trial Update: Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma [Phase 1]

  This is a Phase 1 clinical trial evaluating the safety and preliminary efficacy of bortezomib in combination with CC-5013 (lenalidomide) in …

• CLINICAL_TRIALS trial_result · 2016-01-22
  Clinical Trial Update: Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma [Phase 2]

  Phase 2 clinical trial evaluating a regimen of bortezomib, pegylated liposomal doxorubicin (Doxil), and dexamethasone, with or without thali…

• CLINICAL_TRIALS trial_result · 2016-01-22
  Clinical Trial Update: Japanese Study of BMS-901608 (Elotuzumab) in Combination With Lenalidomide and Low Dose Dexamethasone [Phase 1]

  Phase 1 trial update of elotuzumab in combination with lenalidomide and low-dose dexamethasone in Japanese patients with multiple myeloma ha…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2016-01-06
  Clinical Trial Update: Cancer Stem Cells in Multiple Myeloma

  A clinical trial investigating cancer stem cells in multiple myeloma has completed its study.

• CLINICAL_TRIALS trial_result · 2015-12-24
  Clinical Trial Update: Safety and Dose Study of GRN163L Administered to Treat Patients With Refractory or Relapsed Multiple Myeloma [Phase 1]

  This Phase 1 trial update reports safety and dose information for GRN163L in patients with refractory or relapsed multiple myeloma.

• CLINICAL_TRIALS trial_result · 2015-12-24
  Clinical Trial Update: Safety and Dose Study of GRN163L and Velcade to Treat Patients With Refractory or Relapsed Myeloma [Phase 1]

  Phase 1 safety and dose study of GRN163L with Velcade (bortezomib) in patients with refractory or relapsed multiple myeloma has completed. T…

• CLINICAL_TRIALS trial_result · 2015-12-18
  Clinical Trial Update: Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma [Phase 1, Phase 2]

  Study investigating oral ixazomib in combination with lenalidomide and dexamethasone in newly diagnosed multiple myeloma completed with resu…

• CLINICAL_TRIALS trial_result · 2015-12-14
  Clinical Trial Update: High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies [Phase 1]

  A Phase 1 clinical trial update evaluating high-dose cytarabine in combination with deoxycytidine for acute myeloid leukemia and other hemat…

• CLINICAL_TRIALS trial_result · 2015-12-11
  Clinical Trial Update: Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients [Phase 3]

  Phase 3 trial comparing carfilzomib-dexamethasone to bortezomib-dexamethasone in relapsed multiple myeloma has completed with posted results…

• CLINICAL_TRIALS trial_result · 2015-12-09
  Clinical Trial Update: Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function [Phase 2]

  Phase 2 study assessing safety and pharmacokinetics of carfilzomib in relapsed/refractory multiple myeloma across varying renal function; re…

• CLINICAL_TRIALS trial_result · 2015-12-09
  Clinical Trial Update: Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma [Phase 1, Phase 2]

  ClinicalTrials.gov reports a Phase 1b/2 study of carfilzomib in relapsed solid tumors, multiple myeloma, or lymphoma. The study is completed…

• CLINICAL_TRIALS trial_result · 2015-12-07
  Clinical Trial Update: A Study of Tanespimycin (KOS-953) in Patients With Relapsed-refractory Multiple Myeloma [Phase 2, Phase 3]

  Clinical Trial Update reporting on a Phase 2/Phase 3 study of Tanespimycin (KOS-953) in relapsed-refractory multiple myeloma, with the trial…

• CLINICAL_TRIALS trial_result · 2015-12-04
  Clinical Trial Update: Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma [Phase 1]

  Phase 1 clinical trial evaluating temsirolimus in combination with dexamethasone for recurrent or refractory multiple myeloma; the study has…

• CLINICAL_TRIALS trial_result · 2015-12-03
  Clinical Trial Update: Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma [Phase 2]

  This is a Phase 2 clinical trial update for carfilzomib in relapsed multiple myeloma. The Phase 2 study is completed and results were posted…

• CLINICAL_TRIALS trial_result · 2015-12-03
  Clinical Trial Update: Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies [Phase 1]

  Phase 1 safety study of carfilzomib (PR-171) in hematologic malignancies has completed and results were posted in 2015.

• CLINICAL_TRIALS trial_result · 2015-12-02
  Clinical Trial Update: A Study to Further Assess Safety and Effectiveness Data of the Bortezomib(Velcade)/Melphalan/Prednisone (BMP) Regimen in Previously Untreated and Transplant Ineligible Multiple Myeloma Patients

  This entry updates a clinical trial evaluating the BMP regimen (bortezomib, melphalan, prednisone) for previously untreated, transplant-inel…

• CLINICAL_TRIALS trial_result · 2015-11-30
  Clinical Trial Update: Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells [Phase 1, Phase 2]

  An update on a Phase 1/2 trial evaluating ex vivo expansion of human umbilical cord blood stem and progenitor cells for patients with acute …

• CLINICAL_TRIALS trial_result · 2015-11-20
  Clinical Trial Update: Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma [Phase 2]

  Phase 2 trial evaluating lenalidomide plus rituximab in patients with recurrent or refractory multiple myeloma; the study was terminated wit…

• CLINICAL_TRIALS trial_result · 2015-11-20
  Clinical Trial Update: Geriatric Assessments in Senior Adults With Multiple Myeloma

  This update summarizes a completed clinical trial evaluating geriatric assessments in older adults with multiple myeloma.

• CLINICAL_TRIALS trial_result · 2015-11-13
  Clinical Trial Update: C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT [NA]

  This completed trial assesses the value of C11-acetate PET/CT in multiple myeloma and its added value over F18-FDG PET/CT.

• CLINICAL_TRIALS trial_result · 2015-11-10
  Clinical Trial Update: Japanese Phase 2 Study to Evaluate the Efficacy and Safety of Pomalidomide in Subjects With Relapsed and Refractory Multiple Myeloma [Phase 2]

  A Phase 2 Japanese study evaluating the efficacy and safety of pomalidomide in relapsed and refractory multiple myeloma has completed with r…

• CLINICAL_TRIALS trial_result · 2015-11-10
  Clinical Trial Update: Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer [Phase 1, Phase 2]

  Phase 1/2 trial evaluating donor umbilical cord blood transplant after fludarabine phosphate, cyclophosphamide, and total-body irradiation i…

• CLINICAL_TRIALS trial_result · 2015-11-04
  Clinical Trial Update: IFM2009-02-Pomalidomide and Dexamethasone Phase 2 Myeloma [Phase 2]

  Phase 2 trial evaluating pomalidomide in combination with dexamethasone for multiple myeloma has completed.